uniQure Announces Favorable Recommendation from Independent Data Monitoring Committee for its Phase I/II EPISOD1 Clinical Trial of AMT-162 for the Treatment of SOD1-ALS
30. Januar 2025 07:37 ET
|
uniQure Inc.
~ Independent Data Monitoring Committee Recommends Proceeding with Dose Escalation After Planned Safety Assessment of First Dose Cohort ~ ~ Company Expects to Initiate Enrollment of Second Dose...
MDA Launches 75th Anniversary Campaign and Premieres New PSA to Shine a Light on Rare Diseases
28. Januar 2025 09:00 ET
|
Muscular Dystrophy Association
New York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly announces the launch of its 75th anniversary campaign, marking a legacy of progress in research, care,...
The Sundogs to Host The Tom Petty Show at Variety Playhouse on 2/1, Supporting ALS Research
15. Januar 2025 11:20 ET
|
The Sundogs
ATLANTA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Beloved local rock n’ roll band The Sundogs have announced their 12th annual Tom Petty Show, will be held Saturday, Feb. 1 at Variety Playhouse in the...
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
08. Januar 2025 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Muscular Dystrophy Association and AFM-Téléthon Announce $510,000 Research Grant Awards Advancing Treatments for Mitochondrial Myopathies and ALS
18. Dezember 2024 08:44 ET
|
Muscular Dystrophy Association
New York, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and AFM-Téléthon (the French muscular dystrophy association) are proud to announce the awarding of two...
Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research
16. Dezember 2024 08:42 ET
|
Muscular Dystrophy Association
New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward...
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
06. Dezember 2024 17:30 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and...
NFL Players Nyheim Hines, Raheem Blackshear, Nick Scott, and Wear Custom Cleats to Support Muscular Dystrophy Association for the NFL My Cause My Cleats Campaign
27. November 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Nov. 27, 2024 (GLOBE NEWSWIRE) -- This December, hundreds of NFL players are donning custom-designed cleats as part of the 8th annual My Cause My Cleats campaign, spotlighting non-profit...
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care
21. November 2024 09:00 ET
|
DANNCE.AI
DANNCE.AI Raises $2.6 Million; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform.
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
20. November 2024 05:00 ET
|
Verge Genomics
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics’ AI-Enabled, All-in-Human CONVERGE® Platform — Demonstration of the Robust Predictive Power of CONVERGE® - 83% of...